Literature DB >> 11155191

Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.

F A Spencer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11155191     DOI： 10.1023/a:1027325002276

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  21 in total

1.  Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients.

Authors:  W R Bell; P A Tomasulo; B M Alving; T P Duffy
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

2.  White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases.

Authors:  J C Chang
Journal:  Heart Lung       Date:  1987-07       Impact factor: 2.210

3.  Cerebral venous thrombosis due to heparin-induced thrombocytopenia.

Authors:  A P Kyritsis; E C Williams; H S Schutta
Journal:  Stroke       Date:  1990-10       Impact factor: 7.914

4.  The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.

Authors:  T E Warkentin; L J Elavathil; C P Hayward; M A Johnston; J I Russett; J G Kelton
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

5.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

6.  The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT) (26 cases).

Authors:  A C Benhamou; Y Gruel; J Barsotti; L Castellani; M Marchand; C Guerois; M H Leclerc; B Delahousse; P Griguer; J Leroy
Journal:  Int Angiol       Date:  1985 Jul-Sep       Impact factor: 2.789

7.  Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; C P Hayward; L K Boshkov; A V Santos; J A Sheppard; A P Bode; J G Kelton
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

8.  White clot syndrome. Peripheral vascular complications of heparin therapy.

Authors:  J B Towne; V M Bernhard; C Hussey; J C Garancis
Journal:  Arch Surg       Date:  1979-04

9.  Plasma P-selectin is increased in thrombotic consumptive platelet disorders.

Authors:  B H Chong; B Murray; M C Berndt; L C Dunlop; T Brighton; C N Chesterman
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

10.  Heparin-induced thrombocytopaenia complicated by bilateral adrenal haemorrhage.

Authors:  D Ernest; M M Fisher
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440
View more
  2 in total

1.  Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Authors:  E Magnus Ohman; Christopher B Granger; Lawrence Rice; Charles S Abrams; Richard C Becker; Peter B Berger; Neal S Kleiman; David Moliterno; Stephan Moll; Jo E Rodgers; Stephen S Steinhubl; Victor F Tapson; Peter Sinnaeve; Kevin J Anstrom
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

2.  Effectiveness of a clinical decision support system to identify heparin induced thrombocytopenia.

Authors:  Jeffrey M Riggio; Mandelin K Cooper; Benjamin E Leiby; Jeanine M Walenga; Geno J Merli; Jonathan E Gottlieb
Journal:  J Thromb Thrombolysis       Date:  2008-10-07       Impact factor: 2.300
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.